Naples Hospital Locks In Suppliers Across 46 Pain Therapy and Neurosurgery Device Categories

Standfirst

A.O. dei Colli, the Naples hospital trust, has awarded 46 separate supply lots for pain therapy and functional neurosurgery devices to 15 suppliers, led by Medtronic Italia with nine lots. The tender covers everything from nerve block systems to implantable stimulators, with combined estimated values of roughly 24.6 million euros.

Introduction

Chronic pain and complex neurological conditions often cannot be managed with medication alone. For many patients, relief comes from implantable or minimally invasive devices, nerve stimulators, ganglion block systems, spinal cord devices, that require highly specific, clinically validated technology.

A.O. dei Colli, the Naples hospital trust, has just secured its supply chain for exactly this category of equipment, splitting its needs into 46 distinct product lots and appointing suppliers to each.

Why This Contract Matters

Pain therapy and functional neurosurgery devices sit at a sensitive intersection of clinical need and technical precision. Devices in this tender range from disposable nerve block kits to implantable stimulation systems, each requiring its own regulatory approval, clinical evidence base and specialist supplier relationship.

By awarding 46 separate lots rather than a handful of broad contracts, the hospital ensured that highly specific clinical device categories were matched to suppliers with genuine expertise in that narrow area, rather than forcing a one size fits all procurement onto a clinically diverse set of needs.

Contract Timeline

The notice recording these awards was dispatched on 12 August 2026 and published in the Official Journal of the European Union on 13 August 2026, under OJ S issue 155/2026.

Contract Overview

A.O. dei Colli ran an open procedure under Directive 2014/24/EU for the supply of medical devices and medical systems for pain therapy and functional neurosurgery, classified under CPV code 33158210, Stimulator. The overall estimated value at procedure level was 25,182,140.00 EUR excluding VAT.

The procurement is structured across 46 lots, each covering a distinct device type or clinical application. Summing the individually disclosed lot level estimated values gives approximately 24,602,090.00 EUR, close to but not identical to the procedure level figure, a modest gap the contracting authority has not explained.

Key Contract Details

Project Scope

The lots cover devices used in pain therapy and functional neurosurgery, including integrated systems for transnasal sphenopalatine ganglion block, a nerve block procedure used to treat certain headache and facial pain conditions, alongside a wide range of other stimulation and neuromodulation devices used in specialist pain and neurosurgical care.

Individual lots are narrowly defined by specific device type and clinical configuration, reflecting how precise and non-interchangeable this category of medical technology typically is.

About the Contracting Authority

A.O. dei Colli

A.O. dei Colli is registered as a body governed by public law with general public services as its classified activity, based in Naples. It is a major Neapolitan hospital trust and this procurement secures its supply chain for specialist pain therapy and neurosurgical devices.

About the Organisations Involved

Fifteen distinct suppliers won positions across the 46 lots. MEDTRONIC Italia spa, based in Milan, was the largest winner by far, securing nine lots. SVAS BIOSANA S.p.A., based in San Giuseppe Vesuviano, NG MED S.R.L., based in Pollena Trocchia and MEDINAT S.R.L., based in Naples, each won six lots. DUOMEDICAL SRL and MEDIFOR SRL, both based in the Naples area, won four lots each.

BOSTON SCIENTIFIC S.P.A., based in Milan and CDF MEDICAL SOLUTIONS S.R.L., based in Afragola, each won two lots. The remaining winners, IGEA S.P.A, AV MEDICAL SRL, NEURIMPULSE S.R.L., Gi.Mi. Medical srl, FS MEDICAL, GLA MEDICA S.R.L. and Aion Biotech srl, each secured a single lot.

Procurement Analysis

The winner distribution shows a clear pattern: one large multinational device maker, Medtronic, secured the most lots by a wide margin, while the remainder of the 46 lots were spread across a mix of mid sized and smaller Italian and regionally based medical device suppliers, several clustered around the Naples area.

This pattern is typical of highly segmented clinical device tenders, where a dominant global manufacturer wins the broadest, most standardised product categories, while numerous smaller, more specialised suppliers each win a narrow slice of the tender corresponding to their specific product niche.

Additional Procurement Facts

The notice does not disclose award criteria weighting, tender value per lot, subcontracting status or the number of tenders received for this notice and the contracting authority has not disclosed this information.

Market and Industry Perspective

The winner list reflects the structure of Italy's pain therapy and neuromodulation device market, where a small number of global manufacturers, led here by Medtronic, compete for the largest and most standardised product lines, while a dense network of smaller regional suppliers, many based around Naples, compete for narrower, more specialised device categories.

Economic Significance

At a combined estimated value of roughly 25 million euros across 46 lots, this procurement represents a significant, clinically diverse investment in Naples' specialist pain and neurosurgical care capability.

Future Procurement Opportunities

Given the scale and specificity of this lot structure, A.O. dei Colli is likely to return to the market with a similarly segmented tender once current supply arrangements approach renewal, offering repeated opportunities for both large manufacturers and smaller specialist suppliers.

Opportunities for Suppliers

Smaller and specialist medical device firms should note that 13 of the 15 winners in this tender secured four lots or fewer, confirming that narrowly defined clinical device lots remain genuinely accessible to focused suppliers rather than being dominated entirely by the largest global manufacturers.

What Businesses Should Watch

Medical device suppliers in the pain therapy and neurosurgery space should watch for similar segmented tenders from other Italian hospital trusts, particularly in the Campania region and should monitor renewal timing for this specific contract portfolio.

ItalyTenders.com Procurement Intelligence

This award illustrates how Italian hospitals manage clinically diverse device portfolios by splitting procurement into dozens of narrowly defined lots, allowing both dominant global manufacturers and smaller specialist suppliers to each win the categories that match their specific strengths.

Its strategic importance lies in the balance achieved: Medtronic's nine lot haul confirms its central role in standard neuromodulation supply, while the remaining 37 lots spread across 14 other suppliers show genuine room for smaller, often locally based device firms to compete successfully in this market.

Suppliers targeting future tenders of this kind should recognise that granular, clinically specific lot design is the primary route by which smaller firms can compete against larger manufacturers in Italian hospital device procurement.

Supplier Takeaways

• Medtronic Italia won 9 of 46 lots, the largest share by any single supplier
• 14 other suppliers, many regionally based around Naples, split the remaining 37 lots
• 13 of 15 winners secured four lots or fewer, confirming accessibility for specialist and smaller suppliers
• Award criteria, tender values and competition levels are not disclosed in this notice

Key Takeaways

• A.O. dei Colli has awarded 46 lots for pain therapy and functional neurosurgery devices to 15 suppliers
• Combined estimated lot values total approximately 24.6 million euros against a procedure level estimate of 25.18 million euros
• Medtronic Italia led with nine lots, followed by SVAS Biosana, NG Med and Medinat with six each
• All winning suppliers are based in Italy, with many concentrated in the Naples area

Conclusion

This award secures a diverse, clinically precise supply chain for one of Naples' major hospital trusts, balancing a dominant global manufacturer against a wide base of smaller specialist suppliers. It reflects how granular lot design continues to keep Italian medical device procurement genuinely open to firms of every size.

Source: Tenders Electronic Daily (TED), Contract Award Notice 562036-2026, Official Journal of the European Union, OJ S issue 155/2026, published on 13/08/2026.